The 2025 Respiratory Innovation Summit, hosted by the American Thoracic Society, will bring together innovators, investors, clinicians, and advocacy groups focused on advancing treatments for lung and airway diseases. The event attracts over 390 global leaders from start-ups, business development, venture capital, government, academia, and clinical medicine. Companies working on pulmonary, critical care, or sleep innovations are invited to apply for poster or oral presentations. The agenda includes panels on venture capital, angel investing, and business development, with ample networking opportunities.

Registration includes a networking reception with a keynote on May 16, a full day of programming on May 17, and additional networking events. The Respiratory Innovation Summit is a non-CME program and can be attended separately or as an add-on to the ATS 2025 International Conference